INFORMATION AND SERVICES EXCLUSIVELY FOR US HEALTHCARE PROFESSIONALS

PROMACTA®

WARNING: RISK FOR HEPATIC DECOMPENSATION IN PATIENTS WITH CHRONIC HEPATITIS C

In patients with chronic hepatitis C, PROMACTA in combination with interferon and ribavirin may increase the risk of hepatic decompensation. (See Section 5.1 of the full Prescribing Information for additional information).

...continue reading

155712R0 February 2015